Cena s DPH / bez DPH
Hlavní stránka>BS EN ISO 20186-2:2019 Molecular in vitro diagnostic examinations. Specifications for pre-examination processes for venous whole blood Isolated genomic DNA
sklademVydáno: 2019-05-10
BS EN ISO 20186-2:2019 Molecular in vitro diagnostic examinations. Specifications for pre-examination processes for venous whole blood Isolated genomic DNA

BS EN ISO 20186-2:2019

Molecular in vitro diagnostic examinations. Specifications for pre-examination processes for venous whole blood Isolated genomic DNA

Formát
Dostupnost
Cena a měna
Anglicky Zabezpečené PDF
K okamžitému stažení
6240 Kč
Anglicky Tisk
Skladem
6240 Kč
Označení normy:BS EN ISO 20186-2:2019
Počet stran:30
Vydáno:2019-05-10
ISBN:978 0 539 04949 7
Status:Corrigendum
Popis

BS EN ISO 20186-2:2019


This standard BS EN ISO 20186-2:2019 Molecular in vitro diagnostic examinations. Specifications for pre-examination processes for venous whole blood is classified in these ICS categories:
  • 11.100.10 In vitro diagnostic test systems
  • 11.100.30 Analysis of blood and urine

This document gives guidelines on the handling, storage, processing and documentation of venous whole blood specimens intended for genomic DNA examination during the pre-examination phase before a molecular examination is performed. This document covers specimens collected in venous whole blood collection tubes.

This document is applicable to any molecular in vitro diagnostic examination performed by medical laboratories. It is also intended to be used by laboratory customers, in vitro diagnostics developers and manufacturers, biobanks, institutions and commercial organizations performing biomedical research, and regulatory authorities.

Different dedicated measures are taken for stabilizing blood cell free circulating DNA, which are not described in this document.

NOTE Circulating cell free DNA in blood is covered in ISO 20186‑3.

Different dedicated measures are taken for collecting, stabilizing, transporting and storing capillary blood as well as for collecting and storing blood by paper based technologies or other technologies generating dried blood. These are not described in this document.

This document does not cover the isolation of specific blood cells and subsequent isolation of genomic DNA therefrom.

DNA in pathogens present in blood is not covered by this document.